| Overview |
| bsm-62399r-fitc-100ul |
| NLK Recombinant Antibody, FITC Conjugated |
| WB, FCM |
| Human |
| Specifications |
| FITC |
| Rabbit |
| KLH conjugated synthetic peptide derived from human NLK |
| Recombinant |
| IgG |
| Lot dependent |
| Purified Polyclonal A |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 51701 |
| Q9UBE8 |
| Cytoplasm, Secreted |
| LAK1; Nemo like kinase; Nlk. |
| Serine/threonine-protein kinase that regulates a number of transcription factors with key roles in cell fate determination.Positive effector of the non-canonical Wnt signaling pathway, acting downstream of WNT5A, MAP3K7/TAK1 and HIPK2.Negative regulator of the canonical Wnt/beta-catenin signaling pathway. |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
Powered by Bioz